Canadian Agency for Drugs and Technologies in Health (CADTH)
Canadian Agency for Drugs and Technologies in Health (CADTH).
Int J Technol Assess Health Care. 2017 Jan;33(6):715-723. doi: 10.1017/S0266462317000976. Epub 2017 Nov 10.
Although there is increased awareness of patient and public involvement (PPI) among health technology assessment (HTA) organizations, evaluations of PPI initiatives are relatively scarce. Our objective as members of Health Technology Assessment International's (HTAi's) Patient and Citizen Involvement Group (PCIG) was to advance understanding of the range of evaluation strategies adopted by HTA organizations and their potential usefulness.
In March 2016, a survey was sent to fifty-four HTA organizations through the International Network of Agencies for Health Technology Assessment (INAHTA) and contacts of members of HTAi's PCIG. Respondents were asked about their organizational structure; how patients and members of the public are involved; whether and how PPI initiatives have been evaluated, and, if so, which facilitators and challenges to evaluation were found and how results were used and disseminated.
Fifteen (n = 15) programs from twelve countries responded (response rate 27.8 percent) that involved patients (14/15) and members of the public (10/15) in HTA activities. Seven programs evaluated their PPI activities, including participant satisfaction (5/7), process (5/7) and impact evaluations (4/7). Evaluation results were used to improve PPI activities, identify education and training needs, and direct strategic priorities. Facilitators and challenges revolved around the need for stakeholder buy-in, sufficient resources, senior leadership, and including patients in evaluations.
A small but diverse set of HTA organizations evaluate their PPI activities using a range of strategies that reflect the range of rationales and approaches to PPI in HTA. It will be important for HTA organizations to draw on evaluation theories and methods.
尽管健康技术评估(HTA)组织越来越意识到患者和公众参与(PPI),但对 PPI 计划的评估相对较少。我们作为健康技术评估国际协会(HTAi)患者和公民参与小组(PCIG)成员的目标是增进对 HTA 组织采用的各种评估策略及其潜在用途的理解。
2016 年 3 月,通过国际卫生技术评估机构网络(INAHTA)和 HTAi PCIG 成员的联系,向 54 个 HTA 组织发送了一份调查。受访者被问及他们的组织结构;患者和公众成员如何参与;是否以及如何评估 PPI 计划,如果是,发现了哪些评估的促进因素和挑战,以及如何使用和传播结果。
来自 12 个国家的 15 个(n=15)项目做出了回应(回应率为 27.8%),这些项目涉及 HTA 活动中的患者(14/15)和公众成员(10/15)。7 个项目评估了他们的 PPI 活动,包括参与者满意度(5/7)、过程(5/7)和影响评估(4/7)。评估结果用于改进 PPI 活动、确定教育和培训需求,并指导战略重点。促进因素和挑战主要围绕利益相关者的认同、充足的资源、高层领导以及让患者参与评估的需求。
一小部分但多样化的 HTA 组织使用一系列策略来评估他们的 PPI 活动,这些策略反映了 HTA 中 PPI 的各种理由和方法。HTA 组织将需要借鉴评估理论和方法。